Correlation Between Salesforce and Tema Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Tema Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Tema Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Tema Oncology ETF, you can compare the effects of market volatilities on Salesforce and Tema Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Tema Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Tema Oncology.

Diversification Opportunities for Salesforce and Tema Oncology

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Salesforce and Tema is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Tema Oncology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tema Oncology ETF and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Tema Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tema Oncology ETF has no effect on the direction of Salesforce i.e., Salesforce and Tema Oncology go up and down completely randomly.

Pair Corralation between Salesforce and Tema Oncology

Considering the 90-day investment horizon Salesforce is expected to generate 1.61 times less return on investment than Tema Oncology. In addition to that, Salesforce is 1.48 times more volatile than Tema Oncology ETF. It trades about 0.04 of its total potential returns per unit of risk. Tema Oncology ETF is currently generating about 0.09 per unit of volatility. If you would invest  2,494  in Tema Oncology ETF on November 9, 2024 and sell it today you would earn a total of  61.00  from holding Tema Oncology ETF or generate 2.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Salesforce  vs.  Tema Oncology ETF

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days Salesforce has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Salesforce is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Tema Oncology ETF 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tema Oncology ETF has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Etf's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the fund shareholders.

Salesforce and Tema Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Tema Oncology

The main advantage of trading using opposite Salesforce and Tema Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Tema Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tema Oncology will offset losses from the drop in Tema Oncology's long position.
The idea behind Salesforce and Tema Oncology ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stocks Directory
Find actively traded stocks across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance